ELV Elevance Health, Inc. Common Stock
Elevance Health, Inc. Common Stock について Wikipediaからの企業概要
Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans.
続きを読む
Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans.
Based on its 2021 revenues, the company ranked 20th on the 2022 Fortune 500. In 2023, the company's seat in Forbes Global 2000 rankings was 78. Carelon Global Solutions, Elevance Health's Business Process Outsourcing (BPO)/Shared Services subsidiary, serves the group's offshore and customer service management. It operates sites in India, Puerto Rico, Philippines, and the United States.
History
Anthem
In 1946, Anthem began in Indianapolis, Indiana, as Mutual Hospital Insurance Inc. and Mutual Medical Insurance Inc. The companies grew significantly, controlling 80% of the medical insurance market in Indiana by the 1970s.
In 1972, the two firms, then known as Blue Cross of Indiana and Blue Shield of Indiana, entered into a joint operating agreement.
In 1985, the two companies merged into Associated Insurance Companies, Inc,, later called, The Associated Group, a holding company, but usage of the name "Anthem" persisted. In 1989, the company purchased American General Insurance Co. for $150 million and in 1991, it acquired The Shelby Insurance Co., based in Shelby, Ohio, for $125 million. In 1989, The Associated Group founded Acordia, a brokerage that sold and serviced insurance and employee benefit programs.
In 1993, Acordia acquired American Business Insurance for $130 million and the Federal Kemper Insurance Company for $100 million. The Associated Group merged with Southeastern Mutual Insurance Company, the operator of Blue Cross and Blue Shield of Kentucky. In 1994, it sold Raffensperger, Hughes & Co., Inc., Indiana's largest investment bank, to National City Corp.
In 1995, The Associated Group acquired Community Mutual Insurance, a provider of Blue Cross and Blue Shield insurance plans in Ohio with over 1.9 million policy holders), then set up Anthem Blue Cross and Blue Shield. In 1996, The Associated Group changed its name to Anthem Insurance Company. In August 1997, Anthem acquired Blue Cross and Blue Shield of Connecticut. It also sold Acordia to management.
In 1999, Anthem acquired Blue Cross and Blue Shield of New Hampshire and Blue Cross and Blue Shield of Colorado and Nevada, using debt financing. The acquisitions made since 1996 added 850,000 policy holders. Among its customer base were 2.4 million PPO and 964,000 HMO enrollees.
In 2000, Anthem acquired Blue Cross Blue Shield of Maine. The Gramm-Leach-Bliley Act of 1999 made it possible for Anthem to undergo demutualization and become a public company via an initial public offering, which made it the fourth largest public managed health care company in the United States.
In 2002, Anthem acquired Trigon Healthcare of Virginia, a Blue Cross and Blue Shield plan, the largest insurer in Virginia, for $4.04 billion. Anthem Insurance Company reached 11.9 million members.
Blue Cross of California
Blue Cross of California was the predecessor of WellPoint Health Network Inc.
In 1982, Blue Cross of California was founded with the consolidation of Blue Cross of Northern California (established in 1936) and Blue Cross of Southern California (established in 1937).
In 1992, WellPoint was formed to operate Blue Cross of California's managed care business. In January 1993, Blue Cross of California spun off its managed care business into a publicly traded entity, WellPoint Health Networks Inc. Blue Cross of California retained an 80% interest and voting control.
In 1996, Blue Cross of California restructured to a for-profit corporation, designating WellPoint Health Networks Inc. as the parent organization. In April 1996, WellPoint completed its acquisition of Massachusetts Mutual Life Insurance Company's group life and health insurance subsidiaries for approximately $380 million, making it the second largest publicly held managed health company in the U.S. with 4 million policyholders.
In March 1997, WellPoint acquired the group health and life businesses of John Hancock Financial for $86.7 million. With this acquisition, WellPoint expanded its presence into Michigan, Texas, and the mid-Atlantic, and gained a unit that concentrated on serving the needs of large employers.
In 2000, WellPoint acquired PrecisionRx, a mail service pharmacy fulfillment center in Texas. In March 2000, WellPoint acquired Rush Prudential Health Plans, a Chicago provider, for $204 million. In March 2001, WellPoint acquired Cerulean Companies, the parent company of Blue Cross Blue Shield of Georgia. In 2001, WellPoint offered to acquire CareFirst BlueCross BlueShield for $1.37 billion, including $119 million in bonuses to Carefirst executives. In 2003, the offer was rejected by the Maryland insurance commissioner.
In 2002, WellPoint acquired RightChoice Managed Care, a Missouri-based company that ran Blue Cross and Blue Shield for part of the state, for $1.5 billion. RightChoice also owned provider network company HealthLink. WellPoint also acquired MethodistCare of Houston, Texas and HealthLink. In 2003, WellPoint acquired Golden West Dental and Vision of Camarillo, California, and Cobalt, including Blue Cross and Blue Shield United of Wisconsin.
In November 2004, Wellpoint, Inc. was formed by the merger of Anthem Insurance Company and WellPoint Health Networks Inc. The merger was structured as Anthem acquiring WellPoint Health Networks and renaming itself WellPoint, Inc. WellPoint continued to use 'Anthem' as the brand name under which it operated. It sold its Blue Cross and Blue Shield products in 11 states.
In 2005, WellPoint acquired Alexandria, Virginia–based Lumenos, a provider of consumer-driven health care, for $185 million. Lumenos was the pioneer and market leader in consumer-driven health plans. In December, WellPoint acquired WellChoice, a New York City-based Blue Cross Blue Shield provider, for approximately $6.5 billion, making New York the 14th state in which WellPoint is a Blue Cross Blue Shield licensee.
In 2007, WellPoint acquired Chicago-based American Imaging Management, a radiology benefit management company that creates software to help physicians choose cost-effective locations for their patients to receive medical imaging tests. WellPoint also acquired Chicago-based American Imaging Management (AIM), the leading radiology benefit management company.
In January 2008, Leslie Margolin became the president of California operations. She resigned in July 2010. In 2008, WellPoint acquired Resolution Health, a firm that analyzes patient history for potential medical problems such as adverse drug interactions. In 2009, WellPoint acquired DeCare Dental, a dental insurance firm.
In 2011, WellPoint acquired CareMore, a Cerritos, California-based provider of insurance and care centers for elderly patients. In 2012, WellPoint acquired Amerigroup for $4.9 billion, anticipating significant growth due to Medicaid expansion under the Patient Protection and Affordable Care Act. In August 2012, CEO Angela Braly resigned due to pressure from investors.
On August 13, 2014, WellPoint announced it intended to change its name to Anthem, Inc., effective in December.
Anthem, Inc.
In February 2015, the company acquired Simply Healthcare Holdings, a Medicaid and Medicare managed care company based in Florida. In June 2015, Anthem made an offer to acquire Cigna for more than $54 billion in cash and stock. In February 2017, United States district court Judge Amy Berman Jackson blocked the Cigna merger on grounds of anti-competitive practices. On February 14, Cigna called off its merger agreement with Anthem.
In October 2017, Anthem announced that it would not renew its pharmacy benefit management (PBM) relationship with Express Scripts saying it had been overcharged $3 billion and that instead, Anthem would eventually handle the PBM process itself through its new IngenioRx unit. Anthem announced that it would enter a 5-year contract with CVS Health. Cigna then announced plans in March 2018 to acquire Express Scripts for $58 billion. On November 6, 2017, Gail Koziara Boudreaux was named CEO. In 2018, the company announced a $20 million expansion of its headquarters and the signing of a lease in Atlanta for its technology center. In March 2020, Anthem announced the acquisition of Beacon Health Options, and independently held behavioral health organization.
On February 2, 2021, Anthem announced the acquisition of InnovaCare Health's Puerto Rico subsidiaries including MMM Holdings, LLC ("MMM") and its Medicare Advantage (MA) plan MMM Healthcare, LLC as well as affiliated companies and Medicaid plan. In November 2021, Anthem announced the acquisition of Integra Managed Care in New York. The acquisition of the New York-based international health insurance company was completed on May 5, 2022.
On June 28, 2022, Anthem announced a change of its corporate name to Elevance Health, Inc. and also changed its stock ticker symbol from "ANTM" to "ELV".
Elevance Health
On January 23, 2023, Elevance announced that it entered a definitive agreement to acquire Blue Cross and Blue Shield of Louisiana, increasing Elevance's footprint to 15 states and adding 1.9 million new members. In 2023, Elevance announced that it would rebrand its Amerigroup business as Wellpoint starting in 2024.
As of 2025, Elevance subsidiaries Carelon Behavioral Health and Anthem Blue Cross and Blue Shield are the subject of three lawsuits in New York and Connecticut alleging that they operate ghost networks.
Subsidiaries
Elevance Health includes the following subsidiaries:
Amerigroup
District of Columbia (Medicaid)
Georgia (Medicaid)
New Mexico (Medicare Advantage)
Anthem Blue Cross
California
Blue Cross of California Partnership Plan (Medicaid)
New York (upstate)
Anthem Blue Cross Blue Shield
Colorado
Connecticut
Georgia
Indiana (includes Medicaid)
Kentucky
Anthem Blue Cross and Blue Shield Medicaid
Maine
Missouri (excluding 30 counties in the Kansas City area)
Nevada
Anthem Blue Cross and Blue Shield Healthcare Solutions (Medicaid)
New Hampshire
New York (downstate)
HealthPlus (Medicaid)
Ohio
Virginia (excluding Alexandria City, Arlington County, Falls Church City, and parts of Fairfax County)
HealthKeepers (Medicaid)
Wisconsin
Carelon Behavioral Health
Carelon Behavioral Health of California
Carelon Behavioral Health of Kansas
Carelon Health of Pennsylvania
Carelon Global Solutions (Business Process Outsourcing/Shared Services)
Freedom Health
Florida
Golden West Dental & Vision
California
HealthSun
Florida
MMM
Puerto Rico
Optimum Healthcare
Florida
Simply Healthcare
Florida
UniCare
West Virginia
WellPoint
Arizona (Medicare Advantage)
Iowa (Medicaid and Medicare Advantage)
Maryland (Medicaid)
Massachusetts (government employees)
New Jersey (Medicaid and Medicare Advantage)
Tennessee (Medicaid and Medicare Advantage)
Texas (Medicaid and Medicare Advantage)
Washington (Medicaid and Medicare Advantage)
Joint ventures
Elevance Health operates joint ventures including:
Anthem | MaineHealth (with MaineHealth)
Maine
Blue Medicare Advantage (with Independence Blue Cross)
Pennsylvania
Colorado Community Health Alliance (with Centura Health, Physician Health Partners and Primary Physician Partners)
Colorado
Healthy Blue Kansas (with Blue Cross and Blue Shield of Kansas and Blue Cross and Blue Shield of Kansas City)
Kansas
Healthy Blue Louisiana (with Blue Cross Blue Shield of Louisiana)
Louisiana
Summit Community Care
Arkansas
Centers Plan for Healthy Living
New York, Florida
Quality of care
In 2011, in the category of "Meeting National Standards of Care," California's state patient advocacy office gave Anthem a rating of 2 out of 4 stars. In 2014, it received 3 out of 4 stars in the same category. In 2022, twenty-one of Elevance Health's affiliated Medicaid plans earned accreditation for health equity from the National Committee for Quality Assurance (NCQA).
Controversies
Charitable donations
In 2007, WellPoint pledged to spend $30 million over three years, through the company's charitable foundation, to help the uninsured. In March 2010, the Los Angeles Times reported that WellPoint's tax records and website showed that the company had given only $6.2 million by 2009. The company said that the foundation had indeed fulfilled its $30-million commitment by mid-2009, but refused to provide any financial details to support its claim.
2007 DMHC investigation
In 2007, the California Department of Managed Health Care (DMHC) investigated Anthem's policies for revoking (rescinding) health care insurance policies. The DMHC randomly selected 90 instances where Anthem canceled the insurance of policy holders who had been diagnosed with costly or life-threatening illnesses, to find how many of these cancellations were legal. The agency concluded that all these cancellations were illegal.
In July 2008, Anthem Blue Cross agreed to a settlement with the California Department of Managed Health Care; however in doing so, WellPoint did not officially admit liability. To resolve allegations of improper policy rescissions (cancellations), WellPoint paid $10 million and reinstated plans for 1,770 policy-holders who were affected by cancelled policies. The company also agreed to provide compensation for any medical debts incurred by these policy-holders.
2010 Reuters exposé
In April 2010, Reuters alleged that Wellpoint "using a computer algorithm, identified women recently diagnosed with breast cancer and then singled them out for cancellation of their policies." The software used immediately triggered fraud investigation for those recently diagnosed with the disease as the company searched for some pretext to drop their policies. Wellpoint argued that its algorithm was scanning for diagnostic codes for conditions that patients might have known about during the insurance application. The story not only caused considerable public outrage, but it also led Secretary of Health and Human Services, Kathleen Sebelius, and President Barack Obama, to call on WellPoint to end the practice.
In 2011, Anthem began cancelling policies of members who had been paying premiums with credit cards, sometimes without calling or emailing the member ahead of time.
Opposition to healthcare reform
In August 2009, Anthem, the largest for-profit insurer in California, contacted its employees and urged them to get involved to oppose healthcare reforms proposed during the Obama administration. Consumer Watchdog, a nonprofit watchdog organization in Santa Monica, asked California Attorney General Jerry Brown to investigate its claim that WellPoint had illegally pushed workers to write to their elected officials, attend town hall meetings and enlist family and friends to ensure an overhaul that would match the firm's interests. According to Consumer Watchdog, California's labor code directly prohibits coercive communications, including forbidding employers from controlling, coercing or influencing employees' political activities or affiliations. WellPoint had not been contacted by the California attorney general and had not seen any complaint.
Through 2010 and into 2011, WellPoint senior executives met monthly with executives of other major health insurers to blunt the effect of the Patient Protection and Affordable Care Act.
Premium increases in Maine
In 2009, Anthem Health Plans of Maine, a WellPoint subsidiary, sued the state of Maine for the right to increase premiums further. Since Maine licenses insurance companies through its Bureau of Insurance, Anthem needed the state's permission to raise rates. The Court disagreed with Anthem and found that, unlike with other forms of insurance, the Maine Insurance Code does not require the Superintendent to consider profits.
Rate increases in California
In February 2010, WellPoint announced that rates would increase on some Anthem Blue Cross individual policies in California by as high as 39%. The announcement resulted in an investigation by regulators from the Federal and California governments. Anthem Blue Cross gained worldwide media attention and became a poster child for the problem of rising cost of health care in the U.S. The rate increase came one year after Anthem had raised rates 68% on individual policy holders.
To explain the rate increases, some which were four times the rate of medical inflation, Anthem said the company had experienced a death spiral: the company claimed that with increased unemployment and declining wages, healthy customers dropped their insurance policies. Consequently, the remaining risk pool became sicker and thus more expensive to insure; and, in turn, prices were forced up and pushed more people out of the market.
In response to the outrage from politicians and consumers, Anthem postponed the rate increase until May 1, 2010.
Senator Dianne Feinstein of California proposed giving the Federal government of the United States authority to block insurance premium hikes that it considers to be "unjustified".
WellPoint cost reclassification
On March 17, 2010, WellPoint announced it was reclassifying some of its administrative costs as medical care costs in order to meet loss ratio requirements under the Patient Protection and Affordable Care Act, which requires insurers to spend at least 80% or 85% of customer premiums on health care services, depending on the type of plan.
2009–2010 data breach
In June 2010, Anthem sent letters to 230,000 customers in California warning them that their personal data might have been accessed online via a data breach. After a routine upgrade in October 2009, a third-party vendor stated that all security measures had been properly reinstated, when in fact they had not. As a result, personal information of thousands of coverage applicants who were under the age of 65 was exposed in the open. After a Los Angeles-area woman found that her application for coverage was publicly available, she filed a class action lawsuit against Anthem. While gathering evidence for the proceeding, the woman's lawyers downloaded some confidential customer information from Anthem's website and alerted Anthem about the breach. According to the lawyers, confidential information had remained exposed for five months. Greg Zoeller, Indiana's Attorney General, filed a lawsuit against the company seeking $300,000 in civil penalties for the company alleged failure to notify its consumers about the breach.
Denial of benefits for cancer treatment
In May 2014, Anthem Blue Cross refused to pay for the hospitalization of a Sonoma County, California man for stage four cancers, although he had paid Anthem over $100,000 in premiums. Anthem ended up paying for coverage following public outcry.
2015 data breach
On February 4, 2015, Anthem, Inc. disclosed that criminal hackers had broken into its servers and potentially stolen over 37.5 million records that contain personally identifiable information from its servers. According to Anthem, Inc., the data breach extended into multiple brands Anthem, Inc. uses to market its healthcare plans, including, Anthem Blue Cross, Anthem Blue Cross and Blue Shield, Blue Cross and Blue Shield of Georgia, Empire Blue Cross and Blue Shield, Amerigroup, Caremore, and UniCare. Healthlink was also victimized. Anthem says the medical information and financial data was not compromised. Anthem has offered free credit monitoring in the wake of the breach. According to Bloomberg News, China may be responsible for this data breach. Michael Daniel, chief adviser on cybersecurity for President Barack Obama, said he would be changing his own password. About 80 million company records were hacked, stoking fears that the stolen data could be used for identity theft. The compromised information contained names, birthdays, medical IDs, social security numbers, street addresses, e-mail addresses, employment information and income data. In June 2017, Anthem agreed to spend $115M to settle allegations that it failed to adequately protect the data of its clients, the sum was to be spent on two years of services to protect victims from identity theft. In 2019, two Chinese nationals were indicted for the breach.
"Avoidable ER program"
Beginning in 2015, Anthem has been implementing and expanding its "avoidable ER program" which means not reimbursing ER visits when the cause is not covered by the company. A few patients found out that they had been stuck with bills of over $10,000 that Anthem refused to reimburse. According to a 2013 report by the Journal of the American Medical Association, 87 percent of patients initially triaged as non-urgent ended up with a diagnosis that constituted an emergency. Critics derided the scheme, citing that it was unlawful by federal law to cover a person based on diagnosis, not symptoms. It was also considered unsafe, as it pressured patients to diagnose themselves before going to the ER.
Neglecting complaints
In 2017, the California Department of Managed Health Care fined the company $5 million for untimely response to consumer complaints. In 2019, this was settled at $2.8 million.
2019 lawsuit for coercive direct payments
In 2019, Sovereign Health pressed charges against Anthem, alleging that it was using direct payments to compel them to join Anthem's network under unfavorable terms. Sovereign owns facilities that treat people with addiction and mental health problems.
Diagnostics fraud
In March 2020, Anthem was sued by the Department of Justice. The lawsuit alleges that Anthem had submitted inaccurate diagnostics data in order to obtain increased Medicare reimbursements. In October 2022, a judge ordered Anthem to face the lawsuit.
Medicare Advantage star rating
In January 2024, Elevance Health filed a lawsuit with the Department of Health and Human Services (HHS) challenging changes in the Medicare Advantage star rating methodology. Star ratings are tied to key bonus payouts, and due to the new rating system in 2024 ratings have significantly decreased.
Finances
For the fiscal year 2017, Anthem reported earnings of US$3.843 billion, with an annual revenue of US$90.039 billion, an increase of 6.1% over the previous fiscal cycle. Anthem's shares traded at over $183 per share, and its market capitalization was valued at over US$69.1 billion in October 2018.
Recognition
The company was featured on the S&P Dow Jones Sustainability Index from 2018 to 2022, was named by Fortune as one of the 100 Best Companies to Work For, and was included on the Corporate Equality Index's list of Best Places to Work for LGBTQ Equality from 2015 to 2022.
出典: Wikipedia (英語), CC BY-SA 4.0 · Wikipediaで表示 ↗
ELV 株価スナップショット 価格、時価総額、P/E、EPS、ROE、負債/資本、52週レンジ
ELV 株価チャート 技術指標付きの日次 OHLCV — パン、ズーム、ビューのカスタマイズ
10年間のパフォーマンス 収益、純利益、利益率、EPSのトレンド
バリュエーション P/E、P/S、P/B、EV/EBITDA比率 — 株は割高か割安か?
収益性 粗利益率、営業利益率、純利益率、ROE、ROA、ROIC
財務健全性 負債、流動性、支払能力 — バランスシートの健全性
成長 収益、EPS、純利益の成長率:前年比、3年CAGR、5年CAGR
資本効率 総資産回転率、棚卸資産回転率、売掛金回転率
配当金 利回り、配当性向、配当履歴、5年CAGR
| 権利落ち日 | 金額 |
|---|---|
| 2026年6月10日 | $1.7200 |
| 2026年3月10日 | $1.7200 |
| 2025年12月5日 | $1.7100 |
| 2025年9月10日 | $1.7100 |
| 2025年6月10日 | $1.7100 |
| 2025年3月10日 | $1.7100 |
| 2024年12月5日 | $1.6300 |
| 2024年9月10日 | $1.6300 |
| 2024年6月10日 | $1.6300 |
| 2024年3月7日 | $1.6300 |
| 2023年12月5日 | $1.4800 |
| 2023年9月7日 | $1.4800 |
| 2023年6月8日 | $1.4800 |
| 2023年3月9日 | $1.4800 |
| 2022年12月2日 | $1.2800 |
| 2022年9月8日 | $1.2800 |
| 2022年6月9日 | $1.2800 |
| 2022年3月9日 | $1.2800 |
| 2021年12月2日 | $1.1300 |
| 2021年9月9日 | $1.1300 |
ELV アナリストコンセンサス 強気・弱気のアナリストの見解、12ヶ月の目標株価、アップサイド
- 強い買い 7 24.1%
- 買い 12 41.4%
- 保有 10 34.5%
- 売り 0 0.0%
- 強い売り 0 0.0%
12ヶ月目標株価
21 アナリスト · 2026-08-13決算履歴 EPS実績 vs 予想、サプライズ%、達成率、次回決算日
| 期間 | EPS Actual | EPS 予想 | サプライズ |
|---|---|---|---|
| 2026年6月30日 | $7.45 | $6.27 | 1.2% |
| 2026年3月31日 | $12.58 | $10.93 | 1.6% |
| 2025年12月31日 | $3.33 | $3.13 | 0.20% |
| 2025年9月30日 | $6.03 | $4.98 | 1.0% |
| 2025年6月30日 | $8.84 | $9.04 | -0.20% |
| 2025年3月31日 | $11.97 | $11.50 | 0.47% |
同業他社比較(GICSサブインダストリー) 主要メトリクスとセクターピアの比較
| ティッカー | 時価総額 | P/E | 売上高 YoY | 純利益率 | ROE | 粗利益率 |
|---|---|---|---|---|---|---|
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | — |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | — |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | — |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | — |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| ALHC | $4.03B | — | 46.1% | -0.02% | -0.52% | — |
| CLOV | — | -5.1 | 40.3% | -4.5% | -26.2% | — |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
完全なファンダメンタルズ 年次別全指標 — 損益計算書、貸借対照表、キャッシュフロー
損益計算書 13
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $199.12B | $177.01B | $171.34B | $156.59B | $138.64B | $121.87B | $104.21B | $92.11B | $90.04B | $84.86B | $79.16B | $73.87B | |
| Cost of Revenue | $21.18B | $19.75B | $17.29B | $13.04B | $10.89B | $8.95B | $1.99B | $0 | $0 | · | · | · | |
| SG&A Expense | $20.98B | $20.02B | $20.09B | $17.70B | $15.92B | $17.45B | $13.36B | $14.02B | $12.65B | $12.56B | $12.53B | $11.75B | |
| Operating Income | $7.20B | $7.86B | $8.50B | $8.28B | $7.56B | $6.36B | $6.00B | $5.43B | $4.17B | $4.80B | $4.75B | $4.42B | |
| Interest Expense | · | · | $1.03B | $851M | $798M | $784M | $746M | $753M | $739M | $723M | $653M | $601M | |
| Pretax Income | $6.71B | $7.90B | $7.71B | $7.60B | $8.00B | $6.24B | $5.99B | $5.07B | $3.96B | $4.55B | $4.63B | $4.37B | |
| Income Tax | $1.05B | $1.93B | $1.72B | $1.71B | $1.85B | $1.67B | $1.18B | $1.32B | $121M | $2.08B | $2.07B | $1.81B | |
| Net Income | $5.66B | $5.98B | $5.99B | $5.89B | $6.16B | $4.57B | $4.81B | $3.75B | $3.84B | $2.47B | $2.56B | $2.57B | |
| EPS (Basic) | $25.28 | $25.81 | $25.38 | $24.56 | $25.26 | $18.23 | $18.81 | $14.53 | $14.70 | $9.39 | $9.73 | $9.31 | |
| EPS (Diluted) | $25.21 | $25.68 | $25.22 | $24.28 | $24.95 | $17.98 | $18.47 | $14.19 | $14.35 | $9.21 | $9.38 | $8.99 | |
| Shares (Basic) | 224,000,000 | 231,700,000 | 235,900,000 | 240,000,000 | 243,800,000 | 250,800,000 | 255,500,000 | 258,100,000 | 261,500,000 | 262,900,000 | 263,000,000 | 275,900,000 | |
| Shares (Diluted) | 224,600,000 | 232,900,000 | 237,400,000 | 242,800,000 | 246,800,000 | 254,300,000 | 260,300,000 | 264,200,000 | 267,800,000 | 268,100,000 | 272,900,000 | 285,900,000 | |
| EBITDA | $8.74B | $9.26B | $10.24B | $10.13B | $8.79B | $7.51B | $6.00B | $5.43B | $4.18B | $4.80B | $4.75B | $4.42B |
貸借対照表 26
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9.49B | $8.29B | $6.53B | $7.39B | $4.88B | $5.74B | $4.94B | $3.93B | $3.61B | $4.08B | $2.11B | $2.15B | |
| Other Current Assets | $5.34B | $4.70B | $5.79B | $5.28B | $4.65B | $4.06B | $3.02B | $2.10B | $2.25B | $1.78B | $1.56B | $1.47B | |
| Current Assets | $63.00B | $58.94B | $60.03B | $55.62B | $51.12B | $45.75B | $39.03B | $34.32B | $36.26B | $34.31B | $30.86B | $31.95B | |
| PP&E (Net) | $4.68B | $4.65B | $4.36B | $4.32B | $3.92B | $3.48B | $3.13B | $2.73B | $2.17B | $1.98B | $2.02B | $1.94B | |
| PP&E (Gross) | $8.73B | $8.33B | $7.90B | $7.12B | $8.26B | $7.33B | $6.48B | $5.55B | $4.37B | $4.14B | $4.06B | $3.76B | |
| Accum. Depreciation | $4.06B | $3.68B | $3.54B | $2.80B | $4.34B | $3.84B | $3.35B | $2.81B | $2.20B | $2.16B | $2.04B | $1.82B | |
| Goodwill | $28.34B | $28.28B | $25.32B | $24.38B | $24.23B | $21.69B | $20.50B | $20.50B | $19.23B | $17.56B | $17.56B | $17.08B | |
| Intangibles | $11.20B | $12.09B | $10.27B | $10.31B | $10.62B | $9.40B | $8.67B | $9.01B | $8.37B | $7.96B | $8.16B | $7.96B | |
| Other Non-current Assets | $2.31B | $2.14B | $1.97B | $1.69B | $1.72B | $1.44B | $1.35B | $758M | $565M | $468M | $485M | $512M | |
| Total Assets | $121.49B | $116.89B | $108.93B | $102.75B | $97.46B | $86.61B | $77.45B | $71.57B | $70.54B | $65.08B | $61.72B | $61.68B | |
| Accounts Payable | $7.32B | $6.93B | $6.91B | $5.61B | $4.97B | $5.49B | $4.20B | $4.96B | $5.02B | $4.01B | $3.32B | $3.65B | |
| Short-term Debt | $150M | $365M | $225M | $265M | $275M | $0 | $700M | $1.15B | $1.27B | $440M | $540M | $400M | |
| Current Liabilities | $41.03B | $40.58B | $41.79B | $39.70B | $34.88B | $29.45B | $23.53B | $21.96B | $23.36B | $21.29B | $19.09B | $18.75B | |
| Capital Leases | $529M | $658M | $685M | $751M | $864M | · | · | · | · | · | · | · | |
| Deferred Tax | $2.11B | $2.15B | $1.97B | $2.02B | $2.81B | $2.02B | $2.23B | $1.96B | $1.73B | $2.78B | $2.63B | $2.95B | |
| Other Non-current Liabilities | $3.53B | $3.33B | $1.74B | $1.56B | $1.68B | $1.81B | $1.42B | $1.18B | $925M | $884M | $994M | $1.04B | |
| Total Liabilities | $77.47B | $75.46B | $69.52B | $66.42B | $61.29B | $53.42B | $45.73B | $43.03B | $44.04B | $39.98B | $38.67B | $37.42B | |
| Long-term Debt | $31.90B | $30.87B | $24.89B | $23.85B | $22.76B | $20.04B | $19.39B | $18.07B | $18.66B | $15.29B | $15.32B | $14.64B | |
| Total Debt | $32.05B | $31.23B | $25.12B | $24.11B | $23.03B | $20.04B | $20.09B | $19.21B | $19.93B | $15.73B | $15.86B | $15.15B | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Paid-in Capital | $8.94B | $8.91B | $8.87B | $9.08B | $9.15B | $9.24B | $9.45B | $9.54B | $8.55B | $8.81B | $8.56B | $10.06B | |
| Retained Earnings | $35.39B | $33.55B | $31.75B | $29.65B | $27.14B | $23.80B | $22.57B | $19.99B | $18.05B | $16.56B | $14.78B | $14.01B | |
| AOCI | $-451M | $-1.15B | $-1.31B | $-2.49B | $-197M | $150M | $-296M | $-986M | $-101M | $-268M | $-293M | $172M | |
| Stockholders' Equity | $43.88B | $41.31B | $39.31B | $36.24B | $36.09B | $33.20B | $31.73B | $28.54B | $26.50B | $25.10B | $23.05B | $24.25B | |
| Liabilities + Equity | $121.49B | $116.89B | $108.93B | $102.75B | $97.46B | $86.61B | $77.45B | $71.57B | $70.54B | $65.08B | $61.72B | $61.68B | |
| Shares Outstanding | 220,723,898 | 227,479,695 | 233,071,088 | 237,958,067 | 241,770,746 | 245,401,430 | 252,922,161 | 257,395,577 | 256,084,913 | 263,747,395 | 261,238,188 | 268,109,932 |
キャッシュフロー 18
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.55B | $1.39B | $1.75B | $1.68B | $1.30B | $1.15B | $1.13B | $1.13B | · | · | · | · | |
| Stock-based Comp | $276M | $191M | $289M | $264M | $255M | $283M | $294M | $226M | $170M | $165M | $148M | $169M | |
| Deferred Tax | $-279M | $-374M | $-602M | $-115M | $342M | $-540M | $81M | $91M | $-1.27B | $127M | $-66M | $31M | |
| Amort. of Intangibles | $628M | $580M | $885M | $767M | $441M | $361M | $338M | $358M | $169M | $192M | $230M | $221M | |
| Other Non-cash | $-2.92B | $-1.38B | $642M | $511M | $377M | $5.22B | · | · | · | · | · | · | |
| Operating Cash Flow | $4.29B | $5.81B | $8.06B | $8.40B | $8.36B | $10.69B | $6.06B | $3.83B | $4.18B | $3.27B | $4.21B | $3.37B | |
| CapEx | $1.12B | $1.26B | $1.30B | $1.15B | $1.09B | $1.02B | $1.08B | $1.21B | $791M | $584M | $638M | $715M | |
| Investing Cash Flow | $-1.34B | $-5.17B | $-5.57B | $-4.56B | $-9.64B | $-7.32B | $-2.79B | $-1.26B | $-5.08B | $-514M | $-1.15B | $-975M | |
| Debt Issued | $2.99B | $7.71B | $2.57B | $3.07B | $3.46B | $2.48B | $2.47B | $835M | $5.46B | $0 | $1.23B | $2.70B | |
| Net Debt Issued | $844M | $6.06B | $665M | $1.17B | $2.39B | $552M | $1.35B | $-849M | $2.64B | $0 | $-1.47B | $970M | |
| Stock Issued | · | · | · | · | · | $0 | $0 | $1.25B | $0 | $0 | · | · | |
| Stock Repurchased | $2.60B | $2.90B | $2.68B | $2.32B | $1.90B | $2.70B | $1.70B | $1.69B | $2.00B | $0 | $1.52B | $3.00B | |
| Net Stock Activity | $-2.60B | $-2.90B | $-2.68B | $-2.32B | $-1.90B | $-2.70B | $-1.70B | $-435M | $-2.00B | $0 | $-1.52B | $-3.00B | |
| Dividends Paid | $1.53B | $1.51B | $1.40B | $1.23B | $1.10B | $954M | $818M | $776M | $705M | $684M | $657M | $481M | |
| Financing Cash Flow | $-1.74B | $1.19B | $-3.35B | $-1.32B | $423M | $-2.57B | $-2.27B | $-2.24B | $427M | $-799M | $-3.09B | $-1.82B | |
| Net Change in Cash | $1.20B | $1.83B | $-861M | $2.51B | $-861M | $804M | $1.00B | $325M | $-466M | $1.96B | $-38M | $565M | |
| Free Cash Flow | $3.17B | $4.55B | $6.76B | $7.25B | $7.28B | $9.67B | $4.98B | $2.62B | $3.39B | $2.62B | $3.48B | $2.65B | |
| Levered FCF | · | · | $5.97B | $6.59B | $6.66B | $9.09B | $4.38B | $2.06B | $2.67B | $2.23B | $3.12B | $2.30B |
収益性 7
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.6% | 4.4% | 5.0% | 5.4% | 5.4% | 5.2% | 5.8% | 5.9% | 4.6% | 5.7% | 6.0% | 6.0% | |
| Net Margin | 2.8% | 3.4% | 3.5% | 3.9% | 4.4% | 3.8% | 4.6% | 4.1% | 4.3% | 2.9% | 3.2% | 3.5% | |
| Pretax Margin | 3.4% | 4.5% | 4.5% | 5.0% | 5.7% | 5.1% | 5.7% | 5.5% | 4.4% | 5.4% | 5.9% | 5.9% | |
| EBITDA Margin | 4.4% | 5.2% | 6.0% | 6.5% | 6.3% | 6.2% | 5.8% | 5.9% | 4.6% | 5.7% | 6.0% | 6.0% | |
| ROA | 4.8% | 5.3% | 5.7% | 6.0% | 6.6% | 5.6% | 6.5% | 5.3% | 5.7% | 3.9% | 4.2% | 4.2% | |
| ROE | 13.3% | 14.8% | 15.8% | 16.7% | 17.0% | 13.6% | 15.2% | 13.0% | 14.6% | 9.9% | 11.1% | 10.6% | |
| ROIC | 8.0% | 8.2% | 10.2% | 10.8% | 9.8% | 8.8% | 9.3% | 8.4% | 8.7% | 6.4% | 6.8% | 6.6% |
流動性と支払能力 5
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.5 | 1.4 | 1.4 | 1.5 | 1.6 | 1.7 | 1.6 | 1.6 | 1.6 | 1.6 | 1.7 | |
| Quick Ratio | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | |
| Debt / Equity | 0.7 | 0.8 | 0.6 | 0.7 | 0.6 | 0.6 | 0.6 | 0.7 | 0.8 | 0.6 | 0.7 | 0.6 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.6 | 0.7 | 0.6 | |
| Interest Coverage | · | · | 8.3 | 9.9 | 9.4 | 8.1 | 8.0 | 7.2 | 5.7 | 6.6 | 7.3 | 7.4 |
効率性 1
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.7 | 1.6 | 1.6 | 1.6 | 1.5 | 1.5 | 1.4 | 1.3 | 1.3 | 1.3 | 1.3 | 1.2 |
成長率 10
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 12.5% | 3.3% | 9.4% | 13.0% | 13.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 8.3% | 8.5% | 12.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -1.8% | 1.8% | 3.9% | -2.7% | 38.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 1.3% | 0.97% | 11.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 7.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -5.3% | -0.12% | 1.6% | -4.3% | 34.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -1.3% | -0.97% | 9.4% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 4.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 9.9% | · | · | · | · | · | · | · | · | · | · | · |
バリュエーション(TTM) 17
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $199.12B | $177.01B | $171.34B | $156.59B | $138.64B | $121.87B | $104.21B | $92.11B | $90.04B | $84.86B | $79.16B | $73.87B | |
| Net Income TTM | $5.66B | $5.98B | $5.99B | $5.89B | $6.16B | $4.57B | $4.81B | $3.75B | $3.84B | $2.47B | $2.56B | $2.57B | |
| Market Cap | $77.37B | $83.92B | $109.91B | $122.07B | $112.07B | $78.80B | $76.39B | $67.60B | $57.62B | $37.92B | $36.43B | $33.69B | |
| Enterprise Value | $99.93B | $106.86B | $128.50B | $138.79B | $130.22B | $93.09B | $91.54B | $82.88B | $73.94B | $49.57B | $50.18B | $46.69B | |
| P/E | 13.9 | 14.4 | 18.7 | 21.1 | 18.6 | 17.9 | 16.4 | 18.5 | 15.7 | 15.6 | 14.9 | 14.0 | |
| P/S | 0.4 | 0.5 | 0.6 | 0.8 | 0.8 | 0.6 | 0.7 | 0.7 | 0.6 | 0.4 | 0.5 | 0.5 | |
| P/B | 1.8 | 2.0 | 2.8 | 3.4 | 3.1 | 2.4 | 2.4 | 2.4 | 2.2 | 1.5 | 1.6 | 1.4 | |
| P / Tangible Book | 17.8 | 88.9 | 29.6 | 79.0 | 89.5 | 37.5 | · | · | · | · | · | · | |
| P / Cash Flow | 18.0 | 14.4 | 13.6 | 14.5 | 13.4 | 7.4 | 12.6 | 17.7 | 13.8 | 11.8 | 8.9 | 10.0 | |
| P / FCF | 24.4 | 18.4 | 16.2 | 16.8 | 15.4 | 8.2 | 15.3 | 25.8 | 17.0 | 14.5 | 10.5 | 12.7 | |
| EV / EBITDA | 11.4 | 11.5 | 12.5 | 13.7 | 14.8 | 12.4 | 15.3 | 15.3 | 17.7 | 10.3 | 10.6 | 10.6 | |
| EV / FCF | 31.5 | 23.5 | 19.0 | 19.2 | 17.9 | 9.6 | 18.4 | 31.6 | 21.8 | 18.9 | 14.4 | 17.6 | |
| EV / Revenue | 0.5 | 0.6 | 0.8 | 0.9 | 0.9 | 0.8 | 0.9 | 0.9 | 0.8 | 0.6 | 0.6 | 0.6 | |
| Dividend Yield | 2.0% | 1.8% | 1.3% | 1.0% | 0.99% | 1.2% | 1.1% | 1.1% | 1.2% | 1.8% | 1.8% | 1.4% | |
| Earnings Yield | 7.2% | 7.0% | 5.3% | 4.7% | 5.4% | 5.6% | 6.1% | 5.4% | 6.4% | 6.4% | 6.7% | 7.1% | |
| Payout Ratio | 27.0% | 25.2% | 23.3% | 20.4% | 18.1% | 20.9% | 17.0% | 20.7% | 18.3% | 27.7% | 25.7% | 18.7% | |
| Annual Payout | $1.53B | $1.51B | $1.40B | $1.23B | $1.10B | $954M | $818M | $776M | $705M | $684M | $657M | $481M |
損益計算書 13
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $50.47B | $50.18B | $49.75B | $50.71B | $49.78B | $48.89B | $45.44B | $45.11B | $43.89B | $42.58B | $42.65B | $42.85B | $43.67B | $42.17B | $39.93B | $39.94B | |
| Cost of Revenue | $5.49B | $5.46B | $5.52B | $5.38B | $5.29B | $4.98B | $6.01B | $5.09B | $4.82B | $3.83B | $4.84B | $4.65B | $4.33B | $3.48B | $3.65B | $3.44B | |
| SG&A Expense | $5.55B | $6.33B | $5.42B | $5.27B | $5.00B | $5.30B | $4.80B | $5.27B | $5.07B | $4.89B | $5.00B | $5.47B | $4.82B | $4.80B | $4.57B | $4.52B | |
| Operating Income | $1.76B | $2.09B | $309M | $1.29B | $2.42B | $3.17B | $673M | $1.41B | $2.77B | $3.02B | $1.28B | $1.76B | $2.63B | $2.83B | $1.26B | $2.25B | |
| Interest Expense | · | · | · | · | · | · | · | $300M | $280M | $265M | · | $259M | $261M | $251M | · | $213M | |
| Pretax Income | $1.94B | $2.30B | $215M | $1.41B | $2.29B | $2.80B | $606M | $1.37B | $2.99B | $2.94B | $1.00B | $1.65B | $2.44B | $2.62B | $1.04B | $2.13B | |
| Income Tax | $483M | $544M | $-331M | $219M | $548M | $613M | $193M | $365M | $685M | $690M | $170M | $354M | $585M | $615M | $168M | $529M | |
| Net Income | $1.46B | $1.76B | $547M | $1.19B | $1.74B | $2.18B | $418M | $1.02B | $2.30B | $2.25B | $856M | $1.29B | $1.85B | $1.99B | $865M | $1.60B | |
| EPS (Basic) | $6.74 | $8.03 | $2.58 | $5.32 | $7.74 | $9.64 | $1.87 | $4.38 | $9.91 | $9.65 | $3.70 | $5.48 | $7.83 | $8.37 | $3.66 | $6.69 | |
| EPS (Diluted) | $6.71 | $8.00 | $2.56 | $5.32 | $7.72 | $9.61 | $1.88 | $4.36 | $9.85 | $9.59 | $3.68 | $5.45 | $7.79 | $8.30 | $3.61 | $6.62 | |
| Shares (Basic) | 217,000,000 | 219,800,000 | -450,900,000 | 223,300,000 | 225,200,000 | 226,400,000 | -465,100,000 | 231,900,000 | 232,200,000 | 232,700,000 | -473,500,000 | 235,300,000 | 236,600,000 | 237,500,000 | -481,700,000 | 239,600,000 | |
| Shares (Diluted) | 217,900,000 | 220,400,000 | -452,100,000 | 223,700,000 | 225,800,000 | 227,200,000 | -467,800,000 | 233,100,000 | 233,400,000 | 234,200,000 | -476,600,000 | 236,500,000 | 237,800,000 | 239,700,000 | -487,200,000 | 242,200,000 | |
| EBITDA | $1.76B | $2.44B | · | $1.29B | $2.42B | $3.54B | · | $1.64B | $2.77B | $3.35B | · | $1.76B | $2.63B | $3.29B | · | $2.27B |
貸借対照表 26
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10.23B | $9.66B | $9.49B | $8.71B | $8.56B | $7.50B | $8.29B | $7.87B | $6.50B | $6.23B | · | $10.92B | $9.99B | $10.14B | · | $8.87B | |
| Other Current Assets | $6.28B | $7.17B | $5.34B | $5.21B | $5.41B | $5.29B | $4.70B | $5.95B | $6.46B | $6.39B | · | $5.36B | $4.94B | $4.94B | · | $5.50B | |
| Current Assets | $67.18B | $67.03B | $63.00B | $63.78B | $63.32B | $61.12B | $58.94B | $62.85B | $62.27B | $60.95B | · | $61.19B | $59.74B | $59.82B | · | $55.60B | |
| PP&E (Net) | $4.64B | $4.66B | $4.68B | $4.66B | $4.64B | $4.62B | $4.65B | $4.50B | $4.45B | $4.45B | · | $4.25B | $4.55B | $4.42B | · | $4.20B | |
| PP&E (Gross) | · | · | $8.73B | · | · | · | $8.33B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $4.06B | · | · | · | $3.68B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $28.34B | $28.34B | $28.34B | $28.45B | $28.37B | $28.42B | $28.28B | $25.97B | $25.96B | $25.95B | $25.32B | $25.29B | $25.27B | $25.27B | $24.38B | $24.38B | |
| Intangibles | $10.98B | $11.09B | $11.20B | $11.33B | $11.49B | $11.94B | $12.09B | $10.32B | $10.45B | $10.71B | · | $10.49B | $10.70B | $10.91B | · | $10.54B | |
| Other Non-current Assets | $2.90B | $2.58B | $2.31B | $2.78B | $2.56B | $2.39B | $2.14B | $2.60B | $2.20B | $2.25B | · | $2.33B | $2.13B | $1.86B | · | $2.17B | |
| Total Assets | $126.44B | $125.83B | $121.49B | $122.75B | $121.94B | $119.72B | $116.89B | $116.53B | $112.99B | $111.89B | · | $110.48B | $109.17B | $109.04B | · | $103.03B | |
| Accounts Payable | $6.63B | $6.21B | $7.32B | $6.08B | $7.28B | $7.13B | $6.93B | $6.25B | $5.76B | $5.66B | · | $5.98B | $5.03B | $4.87B | · | $4.96B | |
| Short-term Debt | $0 | $724M | $150M | $180M | $360M | $250M | $365M | $360M | $225M | $1.57B | · | $0 | $265M | $265M | · | $265M | |
| Current Liabilities | $44.25B | $45.31B | $41.03B | $40.88B | $43.83B | $42.70B | $40.58B | $42.03B | $41.81B | $44.33B | · | $43.34B | $41.57B | $41.89B | · | $41.29B | |
| Capital Leases | · | · | $529M | · | · | · | $658M | · | · | · | · | $695M | $717M | $727M | · | $739M | |
| Deferred Tax | $2.21B | $1.79B | $2.11B | $2.31B | $2.01B | $2.12B | $2.15B | $2.09B | $2.04B | $2.20B | · | $1.78B | $1.85B | $2.03B | · | $1.82B | |
| Other Non-current Liabilities | $4.29B | $3.92B | $3.38B | $4.14B | $3.90B | $3.99B | $3.33B | $3.59B | $1.99B | $1.91B | · | $1.97B | $1.78B | $1.65B | · | $1.79B | |
| Total Liabilities | $81.42B | $81.78B | $77.47B | $78.67B | $78.09B | $77.10B | $75.46B | $72.65B | $70.69B | $71.18B | · | $71.94B | $70.86B | $71.58B | · | $66.98B | |
| Long-term Debt | $31.04B | $31.12B | $31.90B | $31.92B | $29.83B | $29.75B | $30.87B | $26.79B | $27.46B | $24.88B | · | $24.84B | $24.86B | $25.20B | · | $23.51B | |
| Total Debt | $31.04B | $31.84B | · | $32.10B | $30.19B | $30.00B | · | $27.15B | $27.69B | $26.45B | · | $24.84B | $25.12B | $25.47B | · | $23.77B | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Paid-in Capital | $8.92B | $8.85B | $8.94B | $8.91B | $8.93B | $8.87B | $8.91B | $9.11B | $9.00B | $8.88B | · | $8.83B | $8.76B | $8.70B | · | $9.17B | |
| Retained Earnings | $36.67B | $35.80B | $35.39B | $35.59B | $35.55B | $34.55B | $33.55B | $35.16B | $34.58B | $33.09B | · | $32.10B | $31.61B | $30.71B | · | $29.60B | |
| AOCI | $-711M | $-741M | $-451M | $-543M | $-760M | $-911M | $-1.15B | $-489M | $-1.39B | $-1.36B | · | $-2.51B | $-2.17B | $-2.05B | · | $-2.78B | |
| Stockholders' Equity | $44.88B | $43.90B | $43.88B | $43.95B | $43.72B | $42.50B | $41.31B | $43.77B | $42.19B | $40.61B | · | $38.42B | $38.20B | $37.36B | · | $35.99B | |
| Liabilities + Equity | $126.44B | $125.83B | $121.49B | $122.75B | $121.94B | $119.72B | $116.89B | $116.53B | $112.99B | $111.89B | · | $110.48B | $109.17B | $109.04B | · | $103.03B | |
| Shares Outstanding | 216,841,146 | 217,368,494 | 220,723,898 | 222,036,187 | 224,835,508 | 225,641,361 | 227,479,695 | 231,929,643 | 231,902,075 | 232,544,717 | · | 234,906,987 | 235,861,650 | 237,114,190 | · | 238,974,624 |
キャッシュフロー 17
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $366M | $354M | $406M | $387M | $380M | $373M | $831M | $231M | $0 | $331M | $1.06B | $220M | $0 | $462M | $473M | $451M | |
| Stock-based Comp | $75M | $55M | $30M | $84M | $81M | $81M | $-29M | $66M | $92M | $62M | $72M | $78M | $78M | $61M | $73M | $69M | |
| Deferred Tax | $151M | $-274M | $-322M | $269M | $-52M | $-174M | $-116M | $-224M | $-170M | $136M | $-241M | $32M | $-138M | $-255M | $68M | $-11M | |
| Amort. of Intangibles | $110M | $112M | $164M | $162M | $147M | $155M | $180M | $122M | $162M | $116M | $217M | $212M | $221M | $235M | $247M | $225M | |
| Other Non-cash | · | $2.43B | · | · | · | $-1.45B | · | · | · | $-797M | · | · | · | $4.21B | · | · | |
| Operating Cash Flow | $1.91B | $4.33B | $84M | $1.14B | $2.05B | $1.02B | $706M | $2.68B | $447M | $1.98B | $-2.97B | $2.61B | $1.95B | $6.47B | $-1.52B | $4.92B | |
| CapEx | $287M | $235M | $293M | $360M | $267M | $196M | $322M | $332M | $323M | $279M | $326M | $319M | $350M | $301M | $298M | $305M | |
| Investing Cash Flow | $159M | $-1.64B | $464M | $-1.22B | $-687M | $103M | $-1.64B | $-401M | $-818M | $-2.31B | $-1.03B | $-687M | $-672M | $-3.18B | $289M | $-1.25B | |
| Debt Issued | · | · | $-3M | $2.99B | · | · | $5.13B | $0 | $2.58B | $0 | $0 | $0 | $0 | $2.57B | $1.78B | $-14M | |
| Net Debt Issued | · | $-750M | · | · | · | $-1.25B | · | · | · | $0 | · | · | · | $666M | · | · | |
| Stock Repurchased | $234M | $1.12B | $471M | $876M | $378M | $880M | $1.81B | $60M | $463M | $566M | $928M | $480M | $646M | $622M | $568M | $579M | |
| Net Stock Activity | · | $-1.12B | · | · | · | $-880M | · | · | · | $-566M | · | · | · | $-622M | · | · | |
| Dividends Paid | $373M | $376M | $377M | $376M | $385M | $386M | $373M | $386M | $378M | $379M | $346M | $348M | $350M | $351M | $305M | $306M | |
| Financing Cash Flow | $-1.49B | $-2.52B | $236M | $243M | $-308M | $-1.91B | $1.41B | $-915M | $668M | $32M | $-394M | $-994M | $-1.43B | $-531M | $-258M | $-1.25B | |
| Net Change in Cash | $575M | $166M | $778M | $153M | $1.06B | $-788M | $468M | $1.37B | $292M | $-300M | $-4.39B | $928M | $-151M | $2.75B | $-1.49B | $2.42B | |
| Free Cash Flow | · | $4.10B | · | · | · | $821M | · | · | · | $1.70B | · | · | · | $6.17B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $1.50B | · | · | · | $5.98B | · | · |
収益性 7
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.5% | 4.2% | · | 2.5% | 4.9% | 6.5% | · | 3.1% | 6.3% | 7.1% | · | 4.1% | 6.0% | 6.7% | · | 5.7% | |
| Net Margin | 2.9% | 3.5% | · | 2.3% | 3.5% | 4.5% | · | 2.2% | 5.2% | 5.3% | · | 3.0% | 4.2% | 4.7% | · | 4.0% | |
| Pretax Margin | 3.8% | 4.6% | · | 2.8% | 4.6% | 5.7% | · | 3.0% | 6.8% | 6.9% | · | 3.9% | 5.6% | 6.2% | · | 5.4% | |
| EBITDA Margin | 3.5% | 4.9% | · | 2.5% | 4.9% | 7.2% | · | 3.6% | 6.3% | 7.9% | · | 4.1% | 6.0% | 7.8% | · | 5.7% | |
| ROA | 1.2% | 1.4% | · | 0.99% | 1.5% | 1.9% | · | 0.90% | 2.1% | 2.0% | · | 1.2% | 1.8% | 1.9% | · | 1.6% | |
| ROE | 3.3% | 4.1% | · | 2.7% | 4.1% | 5.2% | · | 2.5% | 5.7% | 5.8% | · | 3.5% | 5.0% | 5.4% | · | 4.5% | |
| ROIC | 1.7% | 2.1% | · | 1.4% | 2.5% | 3.4% | · | 1.5% | 3.0% | 3.4% | · | 2.2% | 3.2% | 3.5% | · | 2.9% |
流動性と支払能力 5
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.5 | · | 1.6 | 1.4 | 1.4 | · | 1.5 | 1.5 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.3 | |
| Quick Ratio | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.3 | 0.2 | 0.2 | · | 0.2 | |
| Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.7 | 0.7 | · | 0.6 | 0.7 | 0.7 | · | 0.7 | |
| LT Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.6 | 0.7 | · | 0.6 | 0.6 | 0.5 | · | 0.6 | 0.7 | 0.7 | · | 0.6 | |
| Interest Coverage | · | · | · | · | · | · | · | 4.7 | 9.9 | 11.4 | · | 6.8 | 10.1 | 11.3 | · | 10.7 |
効率性 1
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 |
バリュエーション(TTM) 17
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $201.14B | $199.56B | · | $194.48B | $187.66B | $180.46B | · | $174.42B | $172.98B | $171.27B | · | $168.63B | $164.41B | $158.84B | · | $152.49B | |
| Net Income TTM | $6.16B | $6.88B | · | $6.13B | $7.24B | $7.75B | · | $6.85B | $7.69B | $7.38B | · | $6.73B | $7.08B | $7.02B | · | $6.54B | |
| Market Cap | $83.86B | $63.63B | · | $71.74B | $87.45B | $98.14B | · | $120.60B | $125.66B | $120.58B | · | $102.28B | $104.79B | $109.03B | · | $108.55B | |
| Enterprise Value | $104.67B | $85.82B | · | $95.13B | $109.08B | $120.65B | · | $139.89B | $146.85B | $140.81B | · | $116.21B | $119.92B | $124.35B | · | $123.45B | |
| P/E | 13.9 | 9.6 | · | 12.0 | 12.3 | 13.0 | · | 17.8 | 16.6 | 16.7 | · | 15.5 | 15.1 | 15.9 | · | 16.9 | |
| P/S | 0.4 | 0.3 | · | 0.4 | 0.5 | 0.5 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | |
| P/B | 1.9 | 1.4 | · | 1.6 | 2.0 | 2.3 | · | 2.8 | 3.0 | 3.0 | · | 2.7 | 2.7 | 2.9 | · | 3.0 | |
| P / Tangible Book | 15.1 | 14.2 | · | 17.2 | 22.6 | 45.8 | · | 16.1 | 21.7 | 30.5 | · | 38.7 | 47.0 | 93.3 | · | 101.1 | |
| P / Cash Flow | · | 14.7 | · | · | · | 96.5 | · | · | · | 61.0 | · | · | · | 16.9 | · | · | |
| P / FCF | · | 15.5 | · | · | · | 119.5 | · | · | · | 71.0 | · | · | · | 17.7 | · | · | |
| EV / EBITDA | 59.4 | 35.2 | · | 73.5 | 45.0 | 34.1 | · | 85.3 | 53.1 | 42.1 | · | 66.2 | 45.6 | 37.8 | · | 54.4 | |
| EV / FCF | · | 20.9 | · | · | · | 147.0 | · | · | · | 82.9 | · | · | · | 20.2 | · | · | |
| EV / Revenue | 0.5 | 0.4 | · | 0.5 | 0.6 | 0.7 | · | 0.8 | 0.8 | 0.8 | · | 0.7 | 0.7 | 0.8 | · | 0.8 | |
| Dividend Yield | 1.8% | 2.4% | · | 2.1% | 1.8% | 1.6% | · | 1.2% | 1.1% | 1.2% | · | 1.3% | 1.2% | 1.2% | · | 1.1% | |
| Earnings Yield | 7.2% | 10.5% | · | 8.4% | 8.1% | 7.7% | · | 5.6% | 6.0% | 6.0% | · | 6.5% | 6.6% | 6.3% | · | 5.9% | |
| Payout Ratio | 25.5% | 21.3% | · | 32.0% | 22.1% | 17.7% | · | 37.2% | 16.4% | 16.9% | · | 27.0% | 18.9% | 17.6% | · | 18.9% | |
| Annual Payout | $1.50B | $1.51B | · | $1.52B | $1.53B | $1.52B | · | $1.49B | $1.45B | $1.42B | · | $1.35B | $1.31B | $1.27B | · | $1.20B |
財務諸表 損益計算書、貸借対照表、キャッシュフロー — 年次、過去5年間
損益計算書
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 収益 | $199.12B | $177.01B | $171.34B | $156.59B | $138.64B |
| 営業利益率 % | 3.6% | 4.4% | 5.0% | 5.4% | 5.4% |
| 純利益 | $5.66B | $5.98B | $5.99B | $5.89B | $6.16B |
| 希薄化後EPS | $25.21 | $25.68 | $25.22 | $24.28 | $24.95 |
貸借対照表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 負債資本倍率 | 0.7 | 0.8 | 0.6 | 0.7 | 0.6 |
| 流動比率 | 1.5 | 1.5 | 1.4 | 1.4 | 1.5 |
| クイックレシオ | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 |
キャッシュフロー
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| フリーキャッシュフロー | $3.17B | $4.55B | $6.76B | $7.25B | $7.28B |
最新ニュース この会社に言及した最近の見出し
トレードシグナル エントリー価格とリスク/リワード比率を伴う最近の売買シグナル
マイ指標 あなた専用のウォッチリスト — 決算詳細から選択した行
あなたにとって重要なメトリクスを選択 — 上記の決算詳細の任意の行の横にある➕をクリックしてください。
選択内容は保存され、すべてのティッカーで引き継がれます。
機関投資家(13F) 1,773 提出者 · $54.9B合計 · 時点 2026年6月30日
四半期SECフォーム13Fでこの株式の保有を報告している機関。ロングポジションのみ。単一の提出者は、別々のオプションレッグで2回表示される場合があります。 大きな反対売買のプット/コール・レッグは、通常、マーケットメイクまたはヘッジされた在庫を反映しており、方向性への確信を示すものではありません。
| 新規ポジション | 解消済みポジション | 増加 | 減少 | 純株式数増減 |
|---|---|---|---|---|
| 271 (+106 前期比) | 94 (-107 前期比) | 587 (+107 前期比) | 527 (-115 前期比) | +30.8M |
Q1 2026と比較しました。 SECフォーム13Fの提出期限は四半期末から45日後ですが、遅延提出者向けの短いバッファーが含まれます。この期間内の四半期は、直近で完全に報告されたペアを優先するためスキップされます。
| 機関投資家 | 評価額 | 株式数 | % 追跡された13Fのうち | タイプ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $7,274,315,633 | 20,751,150 | 13.26% | 株式数 |
| VANGUARD CAPITAL MANAGEMENT LLC | $5,436,729,233 | 14,058,204 | 9.91% | 株式数 |
| STATE STREET CORP | $4,032,282,885 | 10,426,610 | 7.35% | 株式数 |
| WELLINGTON MANAGEMENT GROUP LLP | $3,179,014,962 | 8,220,244 | 5.80% | 株式数 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2,403,277,896 | 6,214,356 | 4.38% | 株式数 |
| Sanders Capital, LLC | $2,252,711,532 | 5,825,024 | 4.11% | 株式数 |
| Artisan Partners Limited Partnership | $1,771,695,984 | 4,581,222 | 3.23% | 株式数 |
| GEODE CAPITAL MANAGEMENT, LLC | $1,712,764,692 | 4,448,634 | 3.12% | 株式数 |
| NORGES BANK | $1,531,008,381 | 3,958,856 | 2.79% | 株式数 |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $779,725,026 | 2,016,200 | 1.42% | 株式数 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $697,513,963 | 1,803,620 | 1.27% | 株式数 |
| Grantham, Mayo, Van Otterloo & Co. LLC | $654,221,093 | 1,691,671 | 1.19% | 株式数 |
| FMR LLC | $633,317,160 | 1,637,621 | 1.15% | 株式数 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $591,084,393 | 1,528,416 | 1.08% | 株式数 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $588,871,451 | 1,522,694 | 1.07% | 株式数 |
| EAGLE CAPITAL MANAGEMENT LLC | $576,772,638 | 1,491,409 | 1.05% | 株式数 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $511,706,827 | 1,323,163 | 0.93% | 株式数 |
| DIMENSIONAL FUND ADVISORS LP | $511,575,693 | 1,322,824 | 0.93% | 株式数 |
| VANGUARD FIDUCIARY TRUST CO | $461,498,831 | 1,193,336 | 0.84% | 株式数 |
| Ruane, Cunniff & Goldfarb L.P. | $378,839,935 | 979,598 | 0.69% | 株式数 |
| Brave Warrior Advisors, LLC | $377,790,736 | 976,885 | 0.69% | 株式数 |
| Newport Trust Company, LLC | $369,294,278 | 954,915 | 0.67% | 株式数 |
| 1832 Asset Management L.P. | $355,109,795 | 918,237 | 0.65% | 株式数 |
| CITADEL ADVISORS LLC | $293,751,600 | 759,578 | 0.54% | 株式数 |
| Capital International Investors | $290,732,899 | 751,772 | 0.53% | 株式数 |
| MILLENNIUM MANAGEMENT LLC | $281,369,666 | 727,561 | 0.51% | 株式数 |
| BlackRock, Inc. | $268,353,881 | 693,905 | 0.49% | 株式数 |
| High Ground Investment Management LLP | $262,939,273 | 679,904 | 0.48% | 株式数 |
| CANADA PENSION PLAN INVESTMENT BOARD | $261,530,030 | 676,260 | 0.48% | 株式数 |
| Legal & General Group Plc | $259,012,033 | 669,749 | 0.47% | 株式数 |
| ACR Alpine Capital Research, LLC | $254,804,222 | 658,869 | 0.46% | 株式数 |
| Qube Research & Technologies Ltd | $247,577,198 | 640,181 | 0.45% | 株式数 |
| VICTORY CAPITAL MANAGEMENT INC | $240,259,106 | 621,258 | 0.44% | 株式数 |
| Swiss National Bank | $239,610,173 | 619,580 | 0.44% | 株式数 |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $237,525,699 | 614,190 | 0.43% | 株式数 |
| National Pension Service | $228,059,708 | 589,713 | 0.42% | 株式数 |
| GOLDMAN SACHS GROUP INC | $222,913,559 | 576,406 | 0.41% | 株式数 |
| Sumitomo Mitsui Trust Group, Inc. | $220,953,931 | 571,339 | 0.40% | 株式数 |
| Mitsubishi UFJ Asset Management Co., Ltd. | $205,911,600 | 532,437 | 0.38% | 株式数 |
| Ninety One UK Ltd | $196,567,097 | 508,280 | 0.36% | 株式数 |
| ALLIANCEBERNSTEIN L.P. | $191,531,395 | 654,249 | 0.35% | 株式数 |
| FIRST TRUST ADVISORS LP | $189,503,803 | 490,016 | 0.35% | 株式数 |
| Vanguard Global Advisers, LLC | $183,654,210 | 474,890 | 0.33% | 株式数 |
| ENVESTNET ASSET MANAGEMENT INC | $181,045,755 | 468,145 | 0.33% | 株式数 |
| 8 KNOTS MANAGEMENT, LLC | $179,336,122 | 511,585 | 0.33% | 株式数 |
| Focused Investors LLC | $178,514,568 | 461,600 | 0.33% | 株式数 |
| Nuveen Asset Management, LLC | $171,198,670 | 464,079 | 0.31% | 株式数 |
| DAVENPORT & Co LLC | $171,104,235 | 441,940 | 0.31% | 株式数 |
| VANGUARD ASSET MANAGEMENT, Ltd | $167,143,159 | 432,196 | 0.30% | 株式数 |
| Veritas Asset Management LLP | $165,780,323 | 428,672 | 0.30% | 株式数 |
| RHUMBLINE ADVISERS | $161,791,876 | 418,359 | 0.29% | 株式数 |
| California Public Employees Retirement System | $157,606,784 | 407,537 | 0.29% | 株式数 |
| FIL Ltd | $157,293,146 | 406,726 | 0.29% | 株式数 |
| MANNING & NAPIER ADVISORS LLC | $142,522,435 | 367,297 | 0.26% | 株式数 |
| Canoe Financial LP | $140,577,902 | 363,504 | 0.26% | 株式数 |
| YACKTMAN ASSET MANAGEMENT LP | $131,482,399 | 339,985 | 0.24% | 株式数 |
| BANK OF AMERICA CORP /DE/ | $121,697,356 | 314,683 | 0.22% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $121,433,220 | 314,000 | 0.22% | プットオプション |
| AMERIPRISE FINANCIAL INC | $119,565,700 | 309,171 | 0.22% | 株式数 |
| Swedbank AB | $116,986,211 | 302,501 | 0.21% | 株式数 |
| Assenagon Asset Management S.A. | $115,776,907 | 299,374 | 0.21% | 株式数 |
| M&G PLC | $114,210,666 | 295,118 | 0.21% | 株式数 |
| Quantinno Capital Management LP | $112,935,724 | 292,027 | 0.21% | 株式数 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $112,933,654 | 282,040 | 0.21% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $107,897,670 | 279,000 | 0.20% | コールオプション |
| BANK OF NOVA SCOTIA | $101,450,881 | 262,330 | 0.18% | 株式数 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $96,843,749 | 330,807 | 0.18% | 株式数 |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $96,574,989 | 249,722 | 0.18% | 株式数 |
| Caisse de depot et placement du Quebec | $94,418,969 | 244,147 | 0.17% | 株式数 |
| Sound Shore Management Inc /CT/ | $94,150,192 | 243,452 | 0.17% | 株式数 |
| NEW YORK STATE COMMON RETIREMENT FUND | $93,705,452 | 242,302 | 0.17% | 株式数 |
| AMF Tjanstepension AB | $92,093,175 | 238,133 | 0.17% | 株式数 |
| BNP PARIBAS FINANCIAL MARKETS | $91,136,405 | 235,659 | 0.17% | 株式数 |
| MACKENZIE FINANCIAL CORP | $90,587,635 | 234,240 | 0.17% | 株式数 |
| ROYAL LONDON ASSET MANAGEMENT LTD | $89,603,021 | 231,694 | 0.16% | 株式数 |
| JANE STREET GROUP, LLC | $87,130,269 | 225,300 | 0.16% | コールオプション |
| PZENA INVESTMENT MANAGEMENT LLC | $86,849,890 | 224,575 | 0.16% | 株式数 |
| Marathon Asset Management Ltd | $84,882,114 | 219,490 | 0.15% | 株式数 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $84,674,534 | 218,950 | 0.15% | 株式数 |
| BARCLAYS PLC | $79,161,697 | 204,695 | 0.14% | 株式数 |
| RENAISSANCE TECHNOLOGIES LLC | $77,876,980 | 201,373 | 0.14% | 株式数 |
| CITADEL ADVISORS LLC | $77,152,635 | 199,500 | 0.14% | プットオプション |
| AVIVA PLC | $77,089,211 | 199,336 | 0.14% | 株式数 |
| TD Asset Management Inc | $75,328,430 | 194,783 | 0.14% | 株式数 |
| Maple Rock Capital Partners Inc. | $74,058,795 | 191,500 | 0.14% | 株式数 |
| Mawer Investment Management Ltd. | $72,431,822 | 187,293 | 0.13% | 株式数 |
| Freestone Grove Partners LP | $72,096,914 | 186,427 | 0.13% | 株式数 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $71,577,149 | 185,083 | 0.13% | 株式数 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $71,371,408 | 184,551 | 0.13% | 株式数 |
| Orbis Allan Gray Ltd | $70,845,455 | 183,191 | 0.13% | 株式数 |
| Jefferies Financial Group Inc. | $69,850,785 | 180,619 | 0.13% | 株式数 |
| CITADEL ADVISORS LLC | $69,069,978 | 178,600 | 0.13% | コールオプション |
| Korea Investment CORP | $68,952,025 | 178,295 | 0.13% | 株式数 |
| Harvest Portfolios Group Inc. | $68,795,400 | 177,890 | 0.13% | 株式数 |
| RAYMOND JAMES FINANCIAL INC | $68,556,341 | 177,272 | 0.12% | 株式数 |
| LPL Financial LLC | $67,831,262 | 175,397 | 0.12% | 株式数 |
| Alyeska Investment Group, L.P. | $67,228,756 | 173,839 | 0.12% | 株式数 |
| Robeco Institutional Asset Management B.V. | $66,324,193 | 171,500 | 0.12% | 株式数 |
| APG Asset Management N.V. | $66,031,619 | 195,211 | 0.12% | 株式数 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $66,009,784 | 170,687 | 0.12% | 株式数 |
企業インサイダー 92 人のインサイダー · 55人の役員 · 36人の取締役
| インサイダー | 役職 | 最終アクティビティ | 保有株式数 | 12ヶ月購入 | 12ヶ月売却 | 12ヶ月純額 |
|---|---|---|---|---|---|---|
| Gail Boudreaux | President and CEO | 2026年7月17日 P | 171,976 | 2 | 0 | $1,002,230 |
| Brian T Griffin | EVP & CEO, IngenioRx | 2018年5月3日 M | 15,863 | 0 | 0 | $0 |
| Angela F Braly | Chair, President & CEO | 2012年3月1日 A | 476,503 | 0 | 0 | $0 |
| Brian A Sassi | President & CEO Cons, EVP | 2011年6月7日 S | 60,825 | 0 | 0 | $0 |
| Dijuana K Lewis | Pres & CEO CHS and EVP | 2010年5月20日 M | 44,107 | 0 | 0 | $0 |
| Mark L Boxer | Pres & CEO of OT&GS and EVP | 2008年4月4日 F | 42,143 | 0 | 0 | $0 |
| Joan E Herman | President & CEO Cons and EVP | 2007年12月7日 S | 30,369 | 0 | 0 | $0 |
| Mark Kaye | EVP & CFO | 2025年4月24日 S | 18,977 | 0 | 0 | $0 |
| John E Gallina | EVP & Chief Financial Officer | 2023年3月1日 A | 63,725 | 0 | 0 | $0 |
| Wayne S Deveydt | EVP & Chief Financial Officer | 2016年3月3日 F | 57,957 | 0 | 0 | $0 |
| David C Colby | Vice Chairman, CFO & EVP | 2007年4月4日 F | 343,071 | 0 | 0 | $0 |
| Thomas R Byrd | President, Anthem Specialty | 2004年11月26日 A | 26,580 | 0 | 0 | $0 |
| Michael D Houk | President, National Accounts | 2004年11月4日 M | 18,843 | 0 | 0 | $0 |
| John M Murphy | President, Specialty Business | 2004年5月17日 A | 20,806 | 0 | 0 | $0 |
| Caroline S Matthews | Chief Operating Officer | 2004年12月1日 A | 40,471 | 0 | 0 | $0 |
| Ronald W Penczek | CAO & Controller | 2026年6月12日 S | 3,740 | 0 | 1 | $-148,766 |
| Charles Morgan Kendrick JR | EVP & President, Commercial | 2025年3月3日 A | 10,116 | 0 | 0 | $0 |
| Felicia F Norwood | EVP & President,Gov Health Ben | 2025年3月3日 A | 31,939 | 0 | 0 | $0 |
| Ratnakar Lavu | EVP, Chief Digital & Info Off | 2025年3月3日 A | 4,783 | 0 | 0 | $0 |
| Peter D Haytaian | EVP & Pres Carelon & CarelonRx | 2025年3月3日 A | 26,004 | 0 | 0 | $0 |
| Blair Williams Todt | EVP, CLO & CAO | 2025年1月3日 F | 15,631 | 0 | 0 | $0 |
| Gloria M Mccarthy | EVP & Chief Administrative Off | 2023年3月24日 S | 51,435 | 0 | 0 | $0 |
| Leah Stark | EVP & CHRO | 2021年12月30日 F | 12,403 | 0 | 0 | $0 |
| Jeffrey D. Alter | EVP, IngenioRx & Anthem Health | 2021年10月1日 F | 5,107 | 0 | 0 | $0 |
| Patel Prakash R | EVP & President, DBG | 2021年9月4日 F | 17,230 | 0 | 0 | $0 |
| Thomas C Zielinski | EVP & General Counsel | 2020年11月3日 M | 17,910 | 0 | 0 | $0 |
| Craig E Samitt | EVP & President, DBG | 2018年7月26日 M | 17,274 | 0 | 0 | $0 |
| Joseph Swedish | Executive Chairman | 2018年3月5日 S | 61,419 | 0 | 0 | $0 |
| Jacquelyn H Wolf | EVP & Chief HR Officer | 2018年3月1日 A | 3,105 | 0 | 0 | $0 |
| Jose D. Tomas | EVP & Chief HR Officer | 2017年3月3日 F | 23,927 | 0 | 0 | $0 |
| Samuel R Nussbaum MD | EVP & Chief Medical Officer | 2015年5月19日 M | 110,973 | 0 | 0 | $0 |
| Martin B Silverstein | EVP & Chief Strategy Officer | 2015年5月1日 F | 23,249 | 0 | 0 | $0 |
| Kenneth R Goulet | EVP, Commercial & Specialty | 2015年3月2日 A | 84,281 | 0 | 0 | $0 |
| Richard C Zoretic | EVP, Gov Business Division | 2014年3月3日 A | 53,572 | 0 | 0 | $0 |
| John Cannon | EVP, GC & Chief PAO | 2013年12月13日 S | 99,331 | 0 | 0 | $0 |
| Randal L Brown | EVP & Chief HR Officer | 2013年9月4日 M | 30,332 | 0 | 0 | $0 |
| Lori A Beer | EVP, Specialty Businesses & IT | 2013年5月30日 M | 113,955 | 0 | 0 | $0 |
| Harlan A Levine | EVP, CHS | 2012年8月31日 S | 25,244 | 0 | 0 | $0 |
| Venkata R Madabhushi | EVP Sr Bus & Chf Transfrmn Off | 2012年4月2日 A | 45,237 | 0 | 0 | $0 |
| Miller Martin | SVP & Chief Accounting Officer | 2011年3月1日 A | 29,329 | 0 | 0 | $0 |
| Fluegel M Bradley | EVP, Chief Strategy Officer | 2010年11月5日 M | 52,634 | 0 | 0 | $0 |
| Cynthia S Miller | EVP & Chief Actuary | 2010年3月1日 A | 60,757 | 0 | 0 | $0 |
| Randall J Lewis | EVP & Chief Compliance Officer | 2009年8月7日 M | 13,658 | 0 | 0 | $0 |
| Jamie S Miller | SVP & Chief Accounting Officer | 2008年3月3日 A | 25,710 | 0 | 0 | $0 |
| Alice F Rosenblatt | EVP and Chief Actuary | 2008年1月22日 S | 39,265 | 0 | 0 | $0 |
| John S Watts JR | EVP | 2007年12月7日 S | 108,311 | 0 | 0 | $0 |
| Marjorie W Dorr | EVP | 2007年5月22日 M | 38,951 | 0 | 0 | $0 |
| Michael A Stocker | EVP | 2006年10月23日 M | 42,186 | 0 | 0 | $0 |
| Keith R Faller | EVP | 2006年9月12日 M | 83,290 | 0 | 0 | $0 |
| David S Helwig | EVP | 2006年8月18日 M | 55,055 | 0 | 0 | $0 |
SECフォーム3/4/5提出書類からのインサイダー;純額=公開市場のP/Sのみ
ETF保有状況 213のETFが保有
ウェイトは直接株式保有(N-PORT)のみを反映しています。レバレッジ型またはデリバティブベースのファンドは、表示されていない追加のスワップエクスポージャーを保有している可能性があります。
| ファンド | ウェイト | 単位 | 時点 | ソース |
|---|---|---|---|---|
| IHF · iShares Trust | 7.16% | 226,432 SH | 2026年8月8日 | 日次 |
| GFGF · EA Series Trust | 3.75% | 3,541 NS | 2026年5月29日 | N-PORT |
| MDPL · Northern Lights Fund Trust IV | 3.24% | 5,013 NS | 2026年5月31日 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2.78% | 64,637 NS | 2026年4月30日 | N-PORT |
| ABCS · EA Series Trust | 2.29% | 661 NS | 2026年5月29日 | N-PORT |
| FEGE · RBB Fund Trust | 1.92% | 94,302 NS | 2026年5月31日 | N-PORT |
| QLTY · GMO ETF Trust | 1.75% | 200,065 NS | 2026年5月31日 | N-PORT |
| TOLL · Tema ETF Trust | 1.71% | 2,139 NS | 2026年5月31日 | N-PORT |
| SRHQ · Elevation Series Trust | 1.54% | 7,891 NS | 2026年4月30日 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 1.52% | 65,871 SH | 2026年8月8日 | 日次 |
| BKDV · BNY Mellon ETF Trust II | 1.52% | 55,921 NS | 2026年4月30日 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.47% | 29,253 SH | 2026年8月8日 | 日次 |
| IYH · iShares Trust | 1.38% | 129,988 SH | 2026年8月8日 | 日次 |
| FHLC · FIDELITY COVINGTON TRUST | 1.35% | 102,444 NS | 2026年4月30日 | N-PORT |
| PWV · Invesco Exchange-Traded Fund Trust | 1.34% | 61,033 SH | 2026年8月8日 | 日次 |
| RXL · ProShares Trust | 1.26% | 2,301 NS | 2026年5月31日 | N-PORT |
| VMAX · Lattice Strategies Trust | 1.25% | 1,543 NS | 2026年4月30日 | N-PORT |
| VHT · VANGUARD WORLD FUND | 1.22% | 645,908 SH | 2026年8月8日 | 日次 |
| CURE · Direxion Shares ETF Trust | 1.20% | 4,402 NS | 2026年4月30日 | N-PORT |
| IMCV · iShares Trust | 1.14% | 33,457 SH | 2026年8月8日 | 日次 |
| FTA · First Trust Exchange-Traded AlphaDE… | 1.12% | 38,663 NS | 2026年4月30日 | N-PORT |
| NUDV · Nushares ETF Trust | 1.09% | 1,312 NS | 2026年4月30日 | N-PORT |
| IXJ · iShares Trust | 1.07% | 114,143 SH | 2026年8月8日 | 日次 |
| AVIE · AMERICAN CENTURY ETF TRUST | 1.06% | 278 NS | 2026年5月31日 | N-PORT |
| MFSV · MFS Active Exchange Traded Funds Tr… | 1.04% | 12,508 NS | 2026年5月31日 | N-PORT |
| RDVI · First Trust Exchange-Traded Fund IV | 0.96% | 78,591 NS | 2026年4月30日 | N-PORT |
| PALC · Pacer Funds Trust | 0.96% | 5,883 NS | 2026年4月30日 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.95% | 241,021 SH | 2026年8月8日 | 日次 |
| ESMV · iShares Trust | 0.95% | 190 SH | 2026年8月8日 | 日次 |
| GMOV · GMO ETF Trust | 0.93% | 2,152 NS | 2026年5月31日 | N-PORT |
| EQIN · Columbia ETF Trust I | 0.90% | 6,636 NS | 2026年4月30日 | N-PORT |
| ROUS · Lattice Strategies Trust | 0.77% | 12,014 NS | 2026年4月30日 | N-PORT |
| NULC · Nushares ETF Trust | 0.73% | 1,105 NS | 2026年4月30日 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0.73% | 15,896 SH | 2026年8月8日 | 日次 |
| VLUE · iShares Trust | 0.67% | 162,499 SH | 2026年8月8日 | 日次 |
| CVY · Invesco Exchange-Traded Fund Trust | 0.65% | 2,040 SH | 2026年8月8日 | 日次 |
| FEUS · FlexShares Trust | 0.64% | 1,881 NS | 2026年4月30日 | N-PORT |
| FDLO · FIDELITY COVINGTON TRUST | 0.62% | 23,028 NS | 2026年4月30日 | N-PORT |
| COPY · RBB Fund Trust | 0.60% | 5,260 NS | 2026年5月31日 | N-PORT |
| FBCV · FIDELITY COVINGTON TRUST | 0.60% | 2,551 NS | 2026年4月30日 | N-PORT |
| IMCB · iShares Trust | 0.56% | 24,066 SH | 2026年8月8日 | 日次 |
| FAB · First Trust Exchange-Traded AlphaDE… | 0.55% | 2,039 NS | 2026年4月30日 | N-PORT |
| IDRV · iShares Trust | 0.53% | 129,150 SH | 2026年8月8日 | 日次 |
| FEX · First Trust Exchange-Traded AlphaDE… | 0.53% | 20,983 NS | 2026年4月30日 | N-PORT |
| DIVB · iShares Trust | 0.51% | 22,922 SH | 2026年8月8日 | 日次 |
| FNDX · SCHWAB STRATEGIC TRUST | 0.51% | 327,388 NS | 2026年5月31日 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.50% | 12,217 SH | 2026年8月8日 | 日次 |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0.47% | 13,267,000 | 2026年8月8日 | 日次 |
| XOEF · iShares Trust | 0.47% | 273 SH | 2026年8月8日 | 日次 |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0.46% | 16,507,990 | 2026年8月8日 | 日次 |